Feedback loop of immune regulation by CD4+CD25+ Treg

Immunobiology

Volumn 214, Issue 4, 2009, Pages 291-302

  Jung, Yun Jae ^a,b   Seoh, Ju Young ^a  

^a Ewha Womans University School of Medicine   (South Korea)

^b Gachon University College of Medicine   (South Korea)

Author keywords

Anergy; Feedback; Regulatory T cell; Suppression

Indexed keywords

CD28 ANTIBODY; CD3 ANTIBODY; CELL ANTIBODY; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR ALPHA; OX40 LIGAND; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIGEN EXPRESSION; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CELL EXPANSION; CONTROLLED STUDY; CYTOKINE RELEASE; FEEDBACK SYSTEM; IMMUNOREGULATION; LYMPHOCYTE FUNCTION; LYMPHOCYTE PROLIFERATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; TARGET CELL;

ANIMALS; ANTIGENS, CD28; ANTIGENS, CD3; ANTIGENS, CD4; CELL PROLIFERATION; COCULTURE TECHNIQUES; FEEDBACK, BIOCHEMICAL; FORKHEAD TRANSCRIPTION FACTORS; IMMUNE TOLERANCE; INTERLEUKIN-2; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; LYMPHOCYTE ACTIVATION; MALE; MICE; MICE, INBRED BALB C; MODELS, IMMUNOLOGICAL; PARACRINE COMMUNICATION; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, REGULATORY;

EID: 62749109707     PISSN: 01712985     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.imbio.2008.09.004     Document Type: Article

References (27)

1. Annunziato F., Cosmi L., Liotta F., Lazzeri E., Manetti R., Vanini V., Romagnani P., Maggi E., and Romagnani S. Phenotype, localization, and mechanism of suppression of CD4(+)CD25(+) human thymocytes. J. Exp. Med. 196 (2002) 379-387
2. Conroy H., Marshall N.A., and Mills K.H. TLR ligand suppression or enhancement of Treg cells? A double-edged sword in immunity to tumours. Oncogene 27 (2008) 168-180
3. + regulatory T cell function. Eur. J. Immunol. 34 (2004) 2480-2488
4. + regulatory T cells suppress effector T cell proliferation. Clin. Immunol. 115 (2005) 3-9
5. Fontenot J.D., Rasmussen J.P., Williams L.M., Dooley J.L., Farr A.G., and Rudensky A.Y. Regulatory T cell lineage specification by the forkhead transcription factor foxp3. Immunity 22 (2005) 329-341
6. Hombach A.A., Kofler D., Hombach A., Rappl G., and Abken H. Effective proliferation of human regulatory T cells requires a strong costimulatory CD28 signal that cannot be substituted by IL-2. J. Immunol. 179 (2007) 7924-7931
7. Klein L., Khazaie K., and von Boehmer H. In vivo dynamics of antigen-specific regulatory T cells not predicted from behavior in vitro. Proc. Natl. Acad. Sci. USA 100 (2003) 8886-8891
8. Ko K.H., Odell R., and Nordon R.E. Analysis of cell differentiation by division tracking cytometry. Cytometry A 71 (2007) 773-782
9. Krieg A.M. Development of TLR9 agonists for cancer therapy. J. Clin. Invest. 117 (2007) 1184-1194
10. + regulatory T cell suppressor function by analogs of the selecting peptide. Eur. J. Immunol. 37 (2007) 139-146
11. Levings M.K., Sangregorio R., and Roncarolo M.G. Human cd25(+)cd4(+) t regulatory cells suppress naive and memory T cell proliferation and can be expanded in vitro without loss of function. J. Exp. Med. 193 (2001) 1295-1302
12. + T suppressor cell clones produce transforming growth factor beta, but not interleukin 10, and are distinct from type 1T regulatory cells. J. Exp. Med. 196 (2002) 1335-1346
13. Miyara M., and Sakaguchi S. Natural regulatory T cells: mechanisms of suppression. Trends Mol. Med. 13 (2007) 108-116
14. Nelson B.H. IL-2, regulatory T cells, and tolerance. J. Immunol. 172 (2004) 3983-3988
15. Oberg H.H., Wesch D., Lenke J., and Kabelitz D. An optimized method for the functional analysis of human regulatory T cells. Scand. J. Immunol. 64 (2006) 353-360
16. Ono M., Shimizu J., Miyachi Y., and Sakaguchi S. Control of autoimmune myocarditis and multiorgan inflammation by glucocorticoid-induced TNF receptor family-related protein(high), Foxp3-expressing CD25+ and CD25-regulatory T cells. J. Immunol. 176 (2006) 4748-4756
17. Ono M., Yaguchi H., Ohkura N., Kitabayashi I., Nagamura Y., Nomura T., Miyachi Y., Tsukada T., and Sakaguchi S. Foxp3 controls regulatory T-cell function by interacting with AML1/Runx1. Nature 446 (2007) 685-689
18. Rosenberg S.A., Yang J.C., and Restifo N.P. Cancer immunotherapy: moving beyond current vaccines. Nat. Med. 10 (2004) 909-915
19. + regulatory t cells for immunologic self-tolerance and negative control of immune responses. Annu. Rev. Immunol. 22 (2004) 531-562
20. Sakaguchi S., Sakaguchi N., Asano M., Itoh M., and Toda M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J. Immunol. 155 (1995) 1151-1164
21. + naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state. Int. Immunol. 10 (1998) 1969-1980
22. + immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J. Exp. Med. 188 (1998) 287-296
23. + immunoregulatory T cells is antigen nonspecific. J. Immunol. 164 (2000) 183-190
24. + regulatory T cells. J. Leukoc. Biol. 80 (2006) 458-470
25. + regulatory T cell mediated suppression of auto-antigen specific and polyclonal T cell responses. J. Immunol. Methods 322 (2007) 1-11
26. + regulatory T cells in vivo. J. Exp. Med. 198 (2003) 249-258
27. + regulatory T cells by antigen-processing dendritic cells. J. Exp. Med. 198 (2003) 235-247